ClinicalMetric / Countries / Israel / hepatocellular carcinoma
← 🇮🇱 Israel Trials
🇮🇱 Israel Country × Condition

hepatocellular carcinoma Clinical Trials in Israel

Active clinical trials for hepatocellular carcinoma with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇮🇱 Israel

Active Trials in Israel (1)

NCT07485114
Recruiting

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Enrollment
300 pts
Country
🇮🇱 Israel
Daniel Keizman
View Trial →

Frequently Asked Questions

How many hepatocellular carcinoma clinical trials are active in Israel?
There are currently 1 active clinical trials for hepatocellular carcinoma with sites in Israel, of which 1 are actively recruiting patients.
How can I join a hepatocellular carcinoma clinical trial in Israel?
To join a hepatocellular carcinoma clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hepatocellular carcinoma trials in Israel?
Active hepatocellular carcinoma trials in Israel span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Israel Trials → Global hepatocellular carcinoma Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology